Skip to main content
. 2021 Sep 17;6(6):100806. doi: 10.1016/j.adro.2021.100806

Figure 3.

Fig 3

Projected risk of secondary tumors (expressed as cases of secondary tumors per 10,000 patient-years) for all 9 cases according to stereotactic radiosurgery treatment modality.